Common variable immunodeficiency 14 is a rare immune disorder that makes it hard to fight infections. People with Common variable immunodeficiency 14 often have frequent sinus, ear, lung, or gut infections and may feel tired and unwell. It usually lasts lifelong and can be noticed in older children, teens, or adults. Treatment often includes regular antibody infusions, vaccines when appropriate, and prompt antibiotics for infections. The outlook varies, but many people live long and full lives with careful monitoring and treatment.
Overview
Common variable immunodeficiency 14Symptoms
Early signs of Common variable immunodeficiency 14 include frequent sinus, ear, and lung infections, chronic cough or pneumonia, gut problems like diarrhea, and fatigue. Some develop enlarged lymph nodes or spleen and autoimmune issues, such as low blood counts.
Outlook and prognosis
Many living with Common variable immunodeficiency 14 do well with steady care, especially regular immunoglobulin therapy and prompt treatment of infections. Outlook varies: some develop lung or gut complications, autoimmune issues, or liver problems. Ongoing follow-up helps protect organs and quality of life.
Causes and risk factors
Common variable immunodeficiency 14 stems from a single‑gene change affecting B‑cell signaling, inherited or arising new. Family history is the key risk; parental relatedness can increase chances. Environment and lifestyle don’t cause it, though infections may reveal immune weakness.
Genetic influences
Genetics play a meaningful role in Common variable immunodeficiency 14. Variants in genes that guide immune cell signaling and antibody production can cause or raise risk, often with autosomal dominant or recessive patterns. Still, some families show variable expression or incomplete penetrance.
Diagnosis
Doctors suspect Common variable immunodeficiency 14 based on recurrent infections, low immunoglobulin levels, and poor vaccine responses. Diagnosis of Common variable immunodeficiency 14 is confirmed with immune function testing and genetic tests after ruling out other causes. Imaging may assess complications.
Treatment and drugs
Treatment for Common variable immunodeficiency 14 focuses on preventing infections and protecting organs. Many people receive regular immune globulin infusions (IVIG or SCIG), prompt antibiotics for infections, and vaccines that are safe for weakened immunity. Care may also include monitoring lungs and gut, managing autoimmunity, and tailored preventive care.
Symptoms
Frequent sinus or chest infections can upend plans and leave you drained, and gut troubles may follow soon after. Many people living with Common variable immunodeficiency 14 have lower-than-expected antibody levels, so infections last longer or keep coming back. Early features of Common variable immunodeficiency 14 often include repeat ear, sinus, or lung infections, sometimes starting in school years but also showing up in adults. Features vary from person to person and can change over time.
Many people with Common variable immunodeficiency 14 get repeated ear, sinus, or chest infections. These infections can last longer and may need several courses of antibiotics.
A lingering cough, chest tightness, or wheezing can follow repeated chest infections. Breathing may feel harder during exercise or at night.
Diarrhea, bloating, and stomach cramps can flare with infections or on their own. People with Common variable immunodeficiency 14 may not absorb nutrients well, which can lead to unintentional weight loss.
Vaccines may not 'take' as well in Common variable immunodeficiency 14 because antibody levels are low. Doctors may see low protection on blood tests even after routine shots.
How people usually first notice Common variable immunodeficiency 14?
Many people first notice common variable immunodeficiency 14 when “ordinary” infections stop being ordinary—sinus or ear infections that linger, bronchitis that keeps coming back, or pneumonia that takes longer to clear and recurs within months. For children, the first signs of common variable immunodeficiency 14 can include poor weight gain or growth, frequent gut upset, or infections that need multiple rounds of antibiotics, while teens and adults may see fatigue and repeated sinus or lung infections despite usual care. Doctors often pick it up after a pattern of recurrent infections and low immunoglobulin (antibody) levels on blood tests, or when vaccines don’t produce the expected protection.
Types of Common variable immunodeficiency 14
Common variable immunodeficiency 14 is one of several genetic subtypes of CVID, a condition where the immune system has trouble making effective antibodies. These variants are usually defined by the specific gene involved, which can change how early problems start, how often infections happen, and whether other immune issues show up. People may notice different sets of symptoms depending on their situation. When reading about types of Common variable immunodeficiency, you’ll often see them numbered (like CVID1, CVID2…CVID14) based on the gene or discovery order, and that helps explain why symptoms can vary from person to person.
CVID14 (NFKB1)
This variant is linked to changes in the NFKB1 gene, which acts like a dimmer switch for immune signaling. Many living with CVID14 have low antibody levels, frequent sinus or lung infections, and may develop swollen lymph nodes or an enlarged spleen.
CVID1 (ICOS)
Changes in ICOS can impair the help that T cells give B cells to make antibodies. People with this variant often have recurrent infections and may have fewer of the B-cell types that normally mature into antibody-producing cells.
CVID2 (TNFRSF13B/TACI)
Variants in TACI are common in CVID and can lower the body’s ability to switch to stronger, long-lasting antibodies. Some may also have autoimmune features, like low platelets, alongside repeated ear, sinus, or chest infections.
CVID3 (CD19)
CD19 helps B cells signal properly; when it is altered, B cells struggle to respond to germs. This can mean frequent bacterial infections and poor responses to routine vaccines.
CVID4 (BAFF-R/TNFRSF13C)
BAFF-R supports B-cell survival; variants can reduce mature B cells and antibodies. People may face recurrent respiratory infections and slower recovery from common illnesses.
CVID5 (CD81)
CD81 works with CD19 to stabilize B-cell signaling. Changes here can lead to low immunoglobulins and repeated infections, especially of the airways.
CVID6 (CD20/MS4A1)
CD20 is important for B-cell activation; alterations can blunt antibody production. Many experience sinopulmonary infections and may have reduced memory B cells on testing.
CVID7 (CD21/CR2)
CD21 helps B cells recognize tagged microbes; variants can weaken this recognition. People may have recurrent infections and limited vaccine protection.
CVID8 (CD27)
CD27 supports the formation of memory B cells. When altered, people often have fewer memory B cells and recurring infections starting in childhood or early adulthood.
CVID9 (LRBA)
LRBA variants can cause antibody deficiency plus immune regulation problems. For many, this can mean infections along with autoimmune symptoms or gut inflammation.
CVID10 (CTLA4)
CTLA4 changes can lead to both poor antibody responses and overactive immune reactions. People may have frequent infections, enlarged lymph nodes, autoimmunity, or lung inflammation.
CVID11 (IKZF1)
IKZF1 helps guide immune cell development; variants can broadly affect B-cell maturation. This can present as low immunoglobulins, recurrent infections, and sometimes blood cell autoimmunity.
CVID12 (NFKB2)
NFKB2 is part of the same pathway as NFKB1 and can disrupt immune signaling. People often have recurrent infections and may have hormone-related issues if pituitary function is also affected.
CVID13 (SEC61A1)
SEC61A1 affects protein transport within cells; changes can impede B-cell function. Individuals may have repeated infections and variable severity of antibody deficiency.
CVID14 (IKZF3/AIOLOS)
Variants in IKZF3 can disturb B-cell development and maintenance. This can lead to low antibody levels, frequent respiratory infections, and reduced memory B cells on lab testing.
What genetics can tell you about symptoms
Certain TNFRSF13B (TACI) variants can lead to frequent sinus and lung infections, low antibody levels, and swollen lymph nodes because B cells don’t mature or signal properly. Variants in genes like ICOS or CD19 similarly disrupt B‑cell function, causing recurrent infections and poor vaccine responses.
Causes and risk factors
Common variable immunodeficiency 14 is caused by a change in a single immune gene that weakens B cells that make antibodies. The change may be inherited from a parent or happen for the first time, so family history can raise risk in relatives. Genes set the stage, but environment and lifestyle often decide how the story unfolds. Respiratory viruses, crowded indoor settings, and smoking can raise infection risk and complications, but they do not cause the condition. Risk factors for Common variable immunodeficiency 14 also include a known gene change in the family and, in some families, parents who are closely related.
Environmental and biological risk factors
For Common variable immunodeficiency 14, risk is largely shaped at or before conception rather than by events later in life. Doctors often group risks into internal (biological) and external (environmental). Below are environmental and biological risk factors for Common variable immunodeficiency 14 that experts consider when discussing how it can occur.
Sperm from older fathers naturally accumulates more DNA changes over time. This age-related shift can slightly raise the chance of a new change arising at conception. Most older fathers still have healthy children.
Egg cells also age, which can affect how DNA is handled when pregnancy begins. This may modestly increase the chance of a new change at conception. Most pregnancies in older mothers are healthy.
High-dose radiation to either parent before conception can damage DNA in reproductive cells. In rare cases, this could increase the chance of a new change linked to Common variable immunodeficiency 14. Everyday background radiation and most medical imaging use much lower doses.
Exposure to metals like lead or mercury can increase oxidative stress in sperm or eggs. Some studies link this to more DNA breakage, which could raise the chance of new changes at conception. Overall risk from typical community levels appears low.
Genetic risk factors
Common variable immunodeficiency 14 is linked to a change in a single immune-system gene that disrupts B‑cell signaling and antibody production. In many families, the variant is inherited, though it can also appear for the first time in a child. Risk is not destiny—it varies widely between individuals. Here’s what we know about the genetic causes of Common variable immunodeficiency 14.
Causal gene change: A disease-causing change in a single immune-regulating gene can trigger Common variable immunodeficiency 14. This alters B‑cell development and signaling, lowering antibody levels and weakening defense against infections.
Often dominant: In many families, one altered copy of the gene is enough to raise risk. An affected parent has about a 50% chance to pass the variant to each child.
Reduced penetrance: Not everyone who inherits the variant develops symptoms of Common variable immunodeficiency 14. Carrying a genetic change doesn’t guarantee the condition will appear.
Variable expressivity: Health effects can range from frequent sinus or chest infections to milder findings seen only on blood tests. Even within one family, age of onset and severity can differ.
De novo variants: Sometimes the gene change causing Common variable immunodeficiency 14 arises for the first time in a child. In these cases, neither parent carries the variant, so family history may be negative.
Rare patterns: Occasionally, different inheritance patterns are reported, such as recessive forms in specific families. Genetic counseling can clarify the pattern in your family and recurrence risks.
Modifier genes: Other genetic differences can influence how strongly the main variant affects the immune system. This helps explain why siblings with the same change can have different experiences.
Genetic testing: Panel or targeted testing can identify the causative variant in Common variable immunodeficiency 14. Results can guide cascade testing for relatives and help tailor monitoring.
Lifestyle risk factors
Common variable immunodeficiency 14 is a genetic immune disorder; lifestyle habits do not cause it, but they can influence infection risk, symptom burden, and complications. Understanding how lifestyle affects Common variable immunodeficiency 14 helps people reduce preventable infections and protect lung and gut health. Below are lifestyle risk factors for Common variable immunodeficiency 14 that can meaningfully shape day‑to‑day health.
Frequent close contact with sick individuals, crowded indoor settings, and poor hand hygiene raise infection frequency in CVID14. Planning lower‑risk interactions and prompt handwashing can reduce respiratory and gastrointestinal infections.
Cigarette smoke increases respiratory infections and accelerates airway damage in people with CVID14. Avoiding smoking and secondhand smoke helps protect against bronchiectasis and chronic cough.
Heavy drinking suppresses immune defenses and can worsen liver issues that complicate recurrent infections in CVID14. Limiting alcohol supports infection recovery and reduces medication interactions during treatment.
Regular moderate exercise can improve lung ventilation and airway clearance in CVID14. It may reduce respiratory infections and deconditioning, while intense training during illness can delay recovery.
Risk prevention
You can’t prevent common variable immunodeficiency 14 itself, but you can lower the risk of infections and long-term complications. The focus is on strengthening everyday protection, timely treatments, and regular monitoring so problems are caught early. Prevention works best when combined with regular check-ups. Work with your care team to build a plan that fits your health, home, work, and travel needs.
See your immunology team on a set schedule to adjust treatment as your needs change. Routine visits help catch lung, gut, or autoimmune issues early.
Take IVIG or SCIG exactly as prescribed to replace missing antibodies. Staying on schedule lowers infections and protects organs over time.
Keep up with inactivated vaccines like flu and pneumococcal as advised. Avoid live vaccines unless your immunologist specifically recommends them.
Ask close contacts to stay current on their vaccines to create a protective “cocoon.” Sick contacts should mask, postpone visits, or keep distance until well.
Transmission
Common variable immunodeficiency 14 is not contagious; it doesn’t spread through coughs, touch, sex, or blood. It is passed through genes, and how Common variable immunodeficiency 14 is inherited depends on the specific gene change: many families show an autosomal dominant pattern (each child has a 50% chance to inherit the change), some follow an autosomal recessive pattern (both parents carry the change, with a 25% chance for an affected child), and some cases appear for the first time in a child due to a new (de novo) change. Even when a change is inherited, symptoms can vary widely, and some relatives who carry it may have few or no problems. If you’re planning a pregnancy, a clinical genetics team can explain the genetic transmission of Common variable immunodeficiency 14 in your family and discuss testing options.
When to test your genes
Common variable immunodeficiency 14 is a genetic/congenital immune disorder; consider genetic testing if you have recurrent infections, low immunoglobulins, autoimmune issues, granulomas, or a strong family history. Testing can confirm the diagnosis, guide treatment choices, and inform relatives’ risks. Discuss timing with an immunologist, especially before major vaccines or biologic therapies.
Diagnosis
Frequent sinus or chest infections, lingering coughs, and feeling wiped out by bugs that others shake off often bring people to care. For Common variable immunodeficiency 14, doctors look for a pattern of recurrent infections and low antibody levels, then use targeted tests to confirm the cause. Early and accurate diagnosis can help you plan ahead with confidence. When appropriate, genetic testing can support the diagnosis of Common variable immunodeficiency 14 and guide care for you and your family.
Recurrent ear, sinus, or lung infections that are hard to clear raise suspicion. Doctors also ask about long courses of antibiotics and infections that keep coming back. Symptoms starting in late childhood or adulthood are common.
The exam may find signs like persistent sinus tenderness, crackles in the lungs, or enlarged lymph nodes. Some people have an enlarged spleen or liver. These features support the overall picture but are not specific on their own.
Blood tests check antibody (immunoglobulin) levels, especially IgG, and often IgA and IgM. In CVID, IgG is low, sometimes with low IgA or IgM as well. Results are interpreted alongside your infection history.
Doctors measure how well your immune system makes antibodies after routine vaccines. Poor or short‑lived responses support the diagnosis. This helps confirm that low antibodies are also not working effectively.
Stages of Common variable immunodeficiency 14
Common variable immunodeficiency 14 does not have defined progression stages. The course can vary widely—some people have mostly recurrent infections that come and go, while others develop complications such as lung, gut, or autoimmune problems over time—so there isn’t a single, stepwise pattern. Doctors assess early symptoms of Common variable immunodeficiency 14 along with blood tests that check antibody levels and how well vaccines work; imaging or breathing tests may be used to look for organ involvement when needed. Genetic testing may be offered to clarify certain risks.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, and with Common variable immunodeficiency 14, day‑to‑day life often centers on preventing infections and staying ahead of flare‑ups. Early symptoms of Common variable immunodeficiency 14 can include frequent sinus, ear, or chest infections, and over time some people develop gut issues, enlarged lymph nodes, or autoimmune problems like low blood counts. Prognosis refers to how a condition tends to change or stabilize over time. With consistent care—regular immunoglobulin replacement, prompt treatment of infections, and vaccines as advised—many people with Common variable immunodeficiency 14 lead active lives, work, travel, and raise families.
The outlook is not the same for everyone, but complications drive most long‑term risk. Repeated lung infections can scar the airways (bronchiectasis), which raises the chance of breathing problems later; careful prevention and airway care can slow or avoid this. A subset develop autoimmune disease, chronic gut inflammation, or an enlarged spleen, and a smaller group face higher risks of lymphoma or stomach cancer over decades, so age‑appropriate cancer screening and periodic imaging or endoscopy may be recommended. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
When treatment begins early and is maintained, overall survival for people with Common variable immunodeficiency 14 has improved markedly and can approach that of the general population, especially when lung damage is limited. Mortality is higher in those with severe lung disease, certain autoimmune complications, or cancers, which is why steady follow‑up and rapid care for new symptoms matter. Knowing what to expect can ease some of the worry. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Over years, Common variable immunodeficiency 14 can affect the lungs, gut, blood, and lymph system because immune defenses stay low. Many recall that early symptoms of Common variable immunodeficiency 14 were frequent sinus or chest infections, and over time those infections can leave lasting changes like airway damage. Long-term effects vary widely, and some people have only mild issues while others develop complications that need ongoing care. Healthcare teams often monitor lung function, gut health, and blood counts over time to catch problems early.
Repeated chest infections can scar and widen the airways (bronchiectasis). This can cause a long-lasting cough and breathlessness during daily activities.
Ongoing sinus, ear, and lung infections can continue across years. In Common variable immunodeficiency 14, these infections often last longer and come back more easily.
The immune system can mistakenly target blood cells or glands. This can lead to low platelets, anemia, thyroid issues, or joint inflammation over time.
Lymph nodes and the spleen may stay enlarged. Doctors often watch these findings because size and texture can shift with infections or inflammation.
How is it to live with Common variable immunodeficiency 14?
Living with Common variable immunodeficiency 14 often means planning your days around prevention: frequent handwashing, staying current on vaccines your care team recommends, and acting early when infections start. Many find fatigue and repeated sinus, ear, or lung infections disrupt work, school, and travel, so backup plans, masks in crowded spaces, and regular immunoglobulin infusions become part of the routine. Family, friends, and coworkers may need to adjust—helping with errands during flares, understanding missed events, and following “don’t share germs” house rules—but these supports can make life feel steadier. With a good care team, prompt antibiotics when needed, and consistent infusions, many build reliable rhythms that protect health while preserving the activities they value.
Treatment and drugs
Treatment for Common variable immunodeficiency 14 focuses on preventing and controlling infections, supporting the immune system, and managing complications over time. The mainstay is regular immune globulin (IgG) replacement, given through a vein (IVIG) or under the skin (SCIG), to reduce infections and protect the lungs, sinuses, and gut. Doctors also use targeted antibiotics for active infections and sometimes longer preventive courses if infections keep returning; a doctor may adjust your dose to balance benefits and side effects. If there’s significant lung inflammation, autoimmune problems, or gut disease linked to CVID14, specialists may add medicines that calm the immune system, chosen carefully to avoid raising infection risk. Alongside medical treatment, lifestyle choices play a role, including staying up to date with non-live vaccines, quick evaluation of fevers, good hand hygiene, and lung care like airway clearance if you have chronic cough or bronchiectasis.
Non-drug treatment
Living with Common variable immunodeficiency 14 can mean dealing with repeat sinus or chest infections, fatigue, and stomach upset that interrupt school, work, and family plans. The right non-drug strategies help lower infection risk, protect the lungs and sinuses, and support energy and mood over time. Alongside medicines, non-drug therapies can make day-to-day life more predictable and reduce flare-ups. Your care team can help tailor these steps to your age, health history, and what matters most to you.
Consistent handwashing, well-fitted masks in crowded indoor spaces, and avoiding close contact with sick people lower exposure to germs. For many with Common variable immunodeficiency 14, planning ahead for cold-and-flu season helps prevent setbacks.
Chest physiotherapy, huff coughing, and oscillating devices help move mucus so lungs stay clearer. Some non-drug options are delivered by specialists and can be taught for safe home use.
Daily saline rinses and gentle humidification keep nasal passages moist and wash out irritants. This can ease congestion and may reduce sinus infections in Common variable immunodeficiency 14.
Regular, moderate exercise supports lung function, bone strength, and mood. Start low and build up gradually to avoid overexertion during or after infections.
Your genes may have an impact on how drugs work for you
Some medicines for people with common variable immunodeficiency 14 can work differently depending on gene changes that affect how the immune system signals or how the body processes drugs. Genetics may guide dosing, choice of preventive antibiotics, and monitoring for side effects.
Pharmacological treatments
Treatment focuses on preventing infections, supporting the immune system, and calming inflammation. Most people with Common variable immunodeficiency 14 receive regular immunoglobulin replacement to boost protective antibodies and lower the risk of lung damage. Not everyone responds to the same medication in the same way. Medicines are tailored to infections, lung or gut issues, and any autoimmune problems you may have.
Intravenous (IVIG) or under‑the‑skin (SCIG) immunoglobulin supplies antibodies that the body is missing and reduces sinus, ear, and chest infections. Doses are given on a regular schedule (often every 1–4 weeks) and adjusted to keep infection rates low.
Doctors treat bacterial infections promptly with drugs like amoxicillin‑clavulanate or doxycycline based on the site and likely germs. If infections are frequent, low‑dose azithromycin or trimethoprim‑sulfamethoxazole may be used as prevention. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy).
When viruses or fungi cause trouble, options like acyclovir or valacyclovir, and fluconazole or itraconazole, may be prescribed. Courses can be longer than usual in Common variable immunodeficiency 14 to fully clear infections.
Prednisone can calm autoimmune flares (like low blood counts) or inflammatory lung and gut symptoms; budesonide is sometimes used for gut inflammation. Dosing may be increased or lowered gradually to balance control of symptoms with side effects.
Genetic influences
In Common variable immunodeficiency 14 (CVID14), a change in a single gene interferes with how the immune system matures and makes antibodies. These changes may be passed down in a family or may appear for the first time in the person who is diagnosed. Having a gene change doesn’t always mean you will develop the condition. Even within the same family, some people with the change have frequent infections early in life, while others have milder problems or are diagnosed in adulthood. Genetic testing for Common variable immunodeficiency 14 can help confirm the cause, clarify the chance of passing it on, and shape monitoring plans for close relatives. A genetics team can also walk through what the results mean for future pregnancies and which family members might consider testing.
Is Common variable immunodeficiency 14 genetic?
Genetics play a meaningful role in Common variable immunodeficiency 14. Variants in genes that guide immune cell signaling and antibody production can cause or raise risk, often with autosomal dominant or recessive patterns. Still, some families show variable expression or incomplete penetrance.
Pharmacogenetics—how genetics influence drug effects
Treatment plans for Common variable immunodeficiency 14 increasingly consider the specific gene involved. Most people still receive regular immunoglobulin replacement (IVIG or SCIG), but knowing the exact variant can hint whether targeted medicines might help with autoimmune problems or enlarged lymph nodes. Alongside medical history and treatment goals, genetic testing can help tailor therapy and reduce trial-and-error.
Pharmacogenetics rarely changes how immunoglobulin is dosed, but it can matter for add‑on medicines. If thiopurines are being considered for autoimmunity, clinicians may check TPMT or NUDT15 to reduce the risk of severe side effects; similar gene–drug checks can guide choices or dosing of some antibiotics or pain relievers used in everyday care. In a few monogenic immune conditions that resemble CVID, pathway‑matched drugs are available under specialist supervision, so confirming the exact cause in Common variable immunodeficiency 14 helps your care team explore whether targeted options fit your situation.
Interactions with other conditions
Day to day, people with Common variable immunodeficiency 14 often find that recurring sinus or chest infections interact with asthma or COPD—when airways are already irritated, even a mild bug can hit harder and recovery can take longer. Doctors call it a “comorbidity” when two conditions occur together, and in CVID14 this frequently includes autoimmune problems (like thyroid disease or low blood counts), which can complicate infection control and sometimes require medicines that further lower immune defenses. Because early symptoms of Common variable immunodeficiency 14 can look like repeated colds, bronchitis, or sinusitis, these may be mistaken for standalone issues, and overlapping treatment plans may need to balance antibiotics, inhalers, and immune therapy. Inflammatory gut conditions, celiac-like enteropathy, and liver inflammation can also occur alongside CVID14, which may affect how nutrients are absorbed and how well oral medicines work. Chronic infections and long-term immune activation can lead to lung scarring (bronchiectasis), especially when paired with uncontrolled asthma, and there is a small increased risk of certain lymphomas that calls for routine check-ins. If multiple specialists are involved, coordinated care helps align therapies so that treatment for one problem doesn’t unintentionally worsen another.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described stubborn, lingering infections that didn’t match the usual course—colds that turned into repeated sinus infections, chest infections that kept coming back, and wounds that seemed slow to heal. In families, a few relatives might have been known for “always being sick,” without anyone realizing a shared immune issue was at play. These everyday patterns echo what we now recognize as features of Common variable immunodeficiency 14.
First described in the medical literature as part of a broader group called common variable immunodeficiency (CVID), the condition was initially understood through symptoms: frequent ear, sinus, and lung infections; sometimes gut problems; and, in some, autoimmune issues. Over time, descriptions became more precise as doctors noticed that CVID was not a single disorder, but a collection of related immune problems with different genetic roots. With each decade, laboratory testing improved, showing low levels of protective antibodies and poor responses to vaccines in many people with CVID-like symptoms.
Advances in genetics brought the next shift. Researchers began to identify specific gene changes linked to different CVID subtypes. As medical science evolved, a subset of people with CVID features were found to share changes in particular immune-regulating genes—one of these subgroups came to be known as Common variable immunodeficiency 14. This label signals that the clinical picture looks like CVID, but the underlying cause traces to a defined genetic pathway within the immune system.
From early theories to modern research, the story of Common variable immunodeficiency 14 has followed a path from observation to definition: first noticing recurring infections, then grouping cases by shared lab findings, and finally tying some of those cases to distinct genetic variants. Not every early description was complete, yet together they built the foundation of today’s knowledge. This progress matters in day-to-day care. Knowing the condition’s history helps explain why someone might receive a general CVID diagnosis at first, and later a more specific name like Common variable immunodeficiency 14 when genetic results clarify the cause.
Today, the history continues to evolve. Current studies build on a long tradition of observation, linking specific genetic findings to patterns of onset, infection risk, and response to treatment. While the name may sound technical, its purpose is practical: to guide testing, tailor monitoring, and inform families about what to watch for, including early symptoms of Common variable immunodeficiency 14 such as repeat sinus or chest infections. As research grows, the historical steps that defined CVID and its subtypes keep improving how care is delivered—more targeted, more timely, and more personal.